Premium
Daily Home Hemodialysis Is an Available Option for Renal Replacement Therapy in Spain
Author(s) -
Vega Almudena,
Sequí María José,
Abad Soraya,
Yuste Claudia,
Santos Alba,
Macías Nicolás,
LópezGómez Juan M.
Publication year - 2016
Publication title -
therapeutic apheresis and dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.415
H-Index - 53
eISSN - 1744-9987
pISSN - 1744-9979
DOI - 10.1111/1744-9987.12400
Subject(s) - medicine , hemodialysis , home hemodialysis , renal replacement therapy , erythropoietin , intensive care medicine , emergency medicine
The objective of the present study was to analyze the characteristics and survival of patients from our hospital who started home hemodialysis. We analyzed all patients receiving home hemodialysis from 1969 to 2015 (51 patients; age 45 ± 23 years; men 77%). We collected characteristics, hospital admission, and mortality. After a median follow‐up of 43 (22–76) months, we found 0–1 hospital admissions per year. Sixty‐nine percent received a kidney transplant, and the global mortality was 10%. Survival at 5 years was 96%. Mean equivalent renal urea clearance was 15.6 ± 4.2 mL/min, the β‐2 microglobulin reduction rate was 67 ± 18%, the number of antihypertension drugs was 0.7 ± 0.3, and the erythropoietin resistance index was 3.7 ± 2.1 IU/kg/week/g/dL. Daily home hemodialysis is a viable option for renal replacement therapy and should be offered alongside other therapies.